Language

GRAND OPENING of newly expanded, relocated Fauquier location is Mon, Nov 9. Visit 410 Rosedale Court, Suite 270, Warrenton, for all Fauquier appointments starting Nov 9.
Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.  Explore Upcoming Patient Events – Find events that are right for you and RSVP soon to reserve your spot!

Select Language
Careers
Main Number: 571.350.8400
Clinical Trials: 703.636.1473
New Patient
Refer a Patient
Virginia Cancer Specialists logo

Thoracic / Lung

Address Lung Cancer – Advance Early Detection, Understand Risk Factors, And Access Innovative Treatments For Respiratory Health

Thoracic / Lung Cancer This section will cover non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), and mesothelioma. A diagnosis of lung cancer can feel overwhelming, but understanding the disease, how it is diagnosed, and the treatment options available can help you make informed decisions about your care. Advances in cancer treatment, including […]

Improved Survival with a Chemotherapy Free Option for EGFR Mutated Lung Cancer

3d rendered medically accurate illustration of lung cancer

Living with advanced non–small cell lung cancer (NSCLC) driven by mutations in the EGFR gene can feel overwhelming. For many patients, treatment has meant targeted therapy with the gold standard osimertinib, an oral targeted therapy directed toward the EGFR mutated tumor cells.  Data from the large MARIPOSA trial published in September 2025 in The New […]

Enhancing Lung Cancer Treatment: The Promise of Perioperative Immunotherapy – Samantha DiBenedetto, MD

Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer

Introduction: Lung cancer remains one of the most challenging and life-threatening diseases; however, several exciting treatment advances show promising benefits. A recent study in which Virginia Cancer Specialists participated under the research leadership of Dr. Alex Spira, the AEGEAN trial, was published in the New England Journal of Medicine (NEJM) earlier this month and has shed light […]